GlobeNewsWire
20 Mar 2026, 15:00 UTC · 31w ago
Verdict
Headline takes no side. We score ACRS +0.30 — moderately bullish.
+0.30moderately bullish
More positive than 60% of ticker scores this week
Which stocks this story touches
More positive than 60% of ticker scores this week
The company is announcing the presentation of clinical trial results for its candidate ATI-2138, which typically represents positive progress in drug development.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
10h ago
+1.3%
Price agrees with the score
$3.79 vs $3.74 close before publication (Mar 19) · not market-adjusted
ACRS chart →
